Aptalis Pharma Canada ULC et al v. Par Pharmaceutical, Inc.
| Aptalis Pharma Canada ULC, Forest Laboratories, LLC and Allergan USA, Inc. |
| Par Pharmaceutical, Inc. |
| 1:2016cv01069 |
| November 18, 2016 |
| US District Court for the District of Delaware |
| Wilmington Office |
| New Castle |
| Sue L Robinson |
| Patent |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 19, 2017. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 10 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,350,468 B1. (Attachments: #1 Stipulation of dismissal)(nmfn) |
SO ORDERED, re #9 Stipulation of Dismissal filed by Aptalis Pharma Canada ULC, Allergan USA, Inc., Forest Laboratories, LLC, (CASE CLOSED). Signed by Judge Sue L. Robinson on 4/19/2017. (nmfn)
|
| Filing 9 STIPULATION of Dismissal by Allergan USA, Inc., Aptalis Pharma Canada ULC, Forest Laboratories, LLC. (Blumenfeld, Jack) |
| Filing 8 STIPULATION TO EXTEND TIME to ANSWER Complaint to May 4, 2017 - filed by Par Pharmaceutical, Inc.. (Pascale, Karen) |
|
SO ORDERED, re #8 STIPULATION TO EXTEND TIME to ANSWER Complaint to May 4, 2017 filed by Par Pharmaceutical, Inc., Set/Reset Answer Deadlines: Par Pharmaceutical, Inc. answer due 5/4/2017. Signed by Judge Sue L. Robinson on 3/29/2017. (fms)
|
| Filing 7 WAIVER OF SERVICE returned executed by Forest Laboratories, LLC, Aptalis Pharma Canada ULC, Allergan USA, Inc.: For Par Pharmaceutical, Inc. waiver sent on 2/1/2017, answer due 4/3/2017. (Noreika, Maryellen) |
| Filing 6 REQUEST FOR WAIVER of Service sent to Par Pharmaceutical, Inc. on 2/1/2017 by Allergan USA, Inc., Aptalis Pharma Canada ULC, Forest Laboratories, LLC. Waiver of Service due by 3/3/2017. (Noreika, Maryellen) |
| Case Assigned to Judge Sue L. Robinson. Please include the initials of the Judge (SLR) after the case number on all documents filed. (rjb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Allergan plc (f/k/a Actavis plc) for Allergan USA, Inc., Aptalis Pharma Canada ULC, Forest Laboratories, LLC filed by Allergan USA, Inc., Aptalis Pharma Canada ULC, Forest Laboratories, LLC. (nmg) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,350,468 B1. (nmg) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/7/2016. Date of Expiration of Patent: 12/14/2018.Thirty Month Stay Deadline: 4/7/2019. (nmg) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Filing 1 COMPLAINT for PATENT INFRINGEMENT filed against Par Pharmaceutical, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2033068.) - filed by Forest Laboratories, LLC, Aptalis Pharma Canada ULC, Allergan USA, Inc.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(nmg) |
| Summons Issued with Magistrate Consent Notice attached as to Par Pharmaceutical, Inc. on 11/21/2016. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
